IRWD FY 2018 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$347M+16.2% YoY

Gross Profit

$314M90.6% margin

Operating Income

-$239M-68.9% margin

Net Income

-$282M-81.5% margin

EPS (Diluted)

$-1.85

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$80M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$332M

Total Liabilities

$528M

Stockholders' Equity

-$196M

Cash & Equivalents

$173M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$347M	$298M	+16.2%
Gross Profit	$314M	$279M	+12.6%
Operating Income	-$239M	-$77M	-208.7%
Net Income	-$282M	-$117M	-141.5%